![]() Protalex Protalex is a clinical-stage biopharmaceutical company focused on the development of a class of drugs for treating autoimmune and inflammatory diseases. | ![]() Biocept Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer. | ![]() Exosome Diagnostics Exosome Diagnostics develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. | |
Founding Date | Founding Date 1999 | Founding Date 1993 | Founding Date 2008 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Florham Park, US HQ | Locations San Diego, US HQ | Locations Waltham, US HQ Martinsried, DE Athens, US Huntsville, US Mobile, US Montgomery, US Opelika, US see more |
Employees | Employees 233% decrease | Employees 878% decrease | Employees 992% decrease |
Valuation ($) | Valuation ($) 615.2 k | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $25.9m (FY, 2022) | Revenue (est.) N/A |
Net income | Net income ($5m) (FY, 2018) | Net income ($32.1m) (FY, 2022) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 15.9m | Total funding raised $ 112.1m |

Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.
View company
Exosome Diagnostics develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives.
View company